Monitor for any subsequent registered offering up to $4.0 million; announcement may signal near-term capital needs. The low exercise price ($0.23) indicates potential dilution if the investor exercises the warrant.
Price Chart
Executive Summary
Calidi Biotherapeutics issued a warrant to an accredited investor to purchase up to 17,391,304 shares at $0.23 per share, vesting proportionally as the investor purchases up to $4.0 million of common stock in registered offerings. The warrant, exercisable from September 8, 2026, is a capital-raising mechanism with potential dilution if fully exercised.
Key Financial Metrics
Key Facts
- Issued warrant for 17,391,304 shares at $0.23 exercise price
- Warrant vests based on future registered issuances of up to $4.0 million
- First exercisable September 8, 2026; vesting termination July 8, 2026
- Holder is an accredited investor in a private placement under Rule 506(b)
- Warrant includes a 9.99% beneficial ownership limitation
Financial Impact
Potential proceeds of $4.0 million from full warrant exercise, contingent on vesting through future registered share purchases
Risk Factors
- Significant dilution if warrant fully exercised (17.4M shares)
- Company may need additional capital to fund operations
- Lack of obligation to consummate registered issuances leaves uncertainty
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-022024 |
| Document: form8-k.htm | 0001493152-26-022024 |
| Document: 0001493152-26-022024-index-headers.html | 0001493152-26-022024 |
| Document: 0001493152-26-022024-index.html | 0001493152-26-022024 |
| Document: 0001493152-26-022024.txt | 0001493152-26-022024 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 29, 2026 21w ago | 8-K | — | awaiting T+20 | — | — |
May 8, 2026 24w ago | 8-K | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers